Citation: G. Ragnarsson et G. Bodemar, Treatment of irritable bowel syndrome with loperamide oxide. An open studyto determine optimal dosage, J INTERN M, 248(2), 2000, pp. 165-166
Authors:
Bardhan, KD
Bodemar, G
Geldof, H
Schutz, E
Heath, A
Mills, JG
Jacques, LA
Citation: Kd. Bardhan et al., A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome, ALIM PHARM, 14(1), 2000, pp. 23-34
Citation: G. Ragnarsson et al., Abdominal symptoms are not related to anorectal function in the irritable bowel syndrome, SC J GASTR, 34(3), 1999, pp. 250-258
Authors:
Molinder, H
Wallander, MA
Hallberg, M
Bodemar, G
Citation: H. Molinder et al., Dyspepsia - Acid or stress? A study of controversy - Abandoned by experts,finalized in clinical practice?, SC J GASTR, 34(11), 1999, pp. 1057-1064
Citation: G. Ragnarsson et G. Bodemar, Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatient samples, SC J GASTR, 34(10), 1999, pp. 993-1000
Authors:
Mathiesen, UL
Franzen, LE
Fryden, A
Foberg, U
Bodemar, G
Citation: Ul. Mathiesen et al., The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients, SC J GASTR, 34(1), 1999, pp. 85-91